Trial · NCT01870583
Comparison of Surgical Skin Preps During Cesarean Deliveries
NCT01870583, Not applicable, Completed, Montefiore Medical Center; results first posted 2017-06-19
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Comparison of Surgical Skin Preps During Cesarean Deliveries. Trials, record NCT01870583. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT01870583
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Comparison of Surgical Skin Preps During Cesarean Deliveries
- NCT number
- NCT01870583
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 1,404 participants, actual
- Lead sponsor
- Montefiore Medical Center
- Conditions
- Surgical Site Infection Following Cesarean Delivery
- Interventions
- Iodine povidone, Chlorhexidine, Combination iodine and chlorhexidine
- First posted
- 2013-06-06
- Last updated
- 2017-10-02
- Results first posted
- 2017-06-19
Source ClinicalTrials.gov
Registered outcomes1
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Cesarean Surgical Site Infection | 42 days after delivery | Surgical site infection will follow CDC guidelines: A) Superficial incisional surgical site infection B) Deep incisional surgical site infection or C) Organ/space surgical site infection. |
Source ClinicalTrials.gov
Outcomes1
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Cesarean Surgical Site Infection | 42 days after delivery | Participants | COUNT_OF_PARTICIPANTS |
Source ClinicalTrials.gov
Results by group12
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Cesarean Surgical Site Infection | Combination Iodine and Chlorhexidine | Any SSI: Total combined | 18 | Participants | |
| Cesarean Surgical Site Infection | Chlorhexidine | Any SSI: Total combined | 21 | Participants | |
| Cesarean Surgical Site Infection | Iodine Povidone | Any SSI: Total combined | 21 | Participants | |
| Cesarean Surgical Site Infection | Combination Iodine and Chlorhexidine | SSI: Superficial | 15 | Participants | |
| Cesarean Surgical Site Infection | Chlorhexidine | SSI: Superficial | 15 | Participants | |
| Cesarean Surgical Site Infection | Iodine Povidone | SSI: Superficial | 16 | Participants | |
| Cesarean Surgical Site Infection | Combination Iodine and Chlorhexidine | SSI: Deep | 1 | Participants | |
| Cesarean Surgical Site Infection | Chlorhexidine | SSI: Deep | 3 | Participants | |
| Cesarean Surgical Site Infection | Iodine Povidone | SSI: Deep | 3 | Participants | |
| Cesarean Surgical Site Infection | Combination Iodine and Chlorhexidine | SSI: Organ | 2 | Participants |
1 to 10 of 12Source ClinicalTrials.gov
See all 12 results by groupParticipant flow9
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Combination Iodine and Chlorhexidine | 467 | |
| Overall Study | STARTED | Chlorhexidine | 474 | |
| Overall Study | STARTED | Iodine Povidone | 463 | |
| Overall Study | COMPLETED | Combination Iodine and Chlorhexidine | 456 | |
| Overall Study | COMPLETED | Chlorhexidine | 456 | |
| Overall Study | COMPLETED | Iodine Povidone | 455 | |
| Overall Study | NOT COMPLETED | Combination Iodine and Chlorhexidine | 11 | |
| Overall Study | NOT COMPLETED | Chlorhexidine | 18 | |
| Overall Study | NOT COMPLETED | Iodine Povidone | 8 |
Source ClinicalTrials.gov
Adverse events3
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| serious | Surgical site infection: organ | Infections and infestations | Combination Iodine and Chlorhexidine | 2 | 467 | |
| serious | Surgical site infection: organ | Infections and infestations | Chlorhexidine | 3 | 474 | |
| serious | Surgical site infection: organ | Infections and infestations | Iodine Povidone | 2 | 463 |
Source ClinicalTrials.gov
Adverse event totals9
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Combination Iodine and Chlorhexidine | 0 | 467 |
| Total, all-cause mortality | Chlorhexidine | 0 | 474 |
| Total, all-cause mortality | Iodine Povidone | 0 | 463 |
| Total, other adverse events | Combination Iodine and Chlorhexidine | 0 | 467 |
| Total, other adverse events | Chlorhexidine | 0 | 474 |
| Total, other adverse events | Iodine Povidone | 0 | 463 |
| Total, serious adverse events | Combination Iodine and Chlorhexidine | 2 | 467 |
| Total, serious adverse events | Chlorhexidine | 3 | 474 |
| Total, serious adverse events | Iodine Povidone | 2 | 463 |
Source ClinicalTrials.gov
Papers11
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT01870583
GET https://conductscience.org/api/trials/v1/NCT01870583/registered